Overview
| Uniprot ID | P05161 |
| Protein Name | Ubiquitin-like protein ISG15 |
| Gene Name | ISG15 |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position |
Flanking peptide |
| 77 |
TVLLVVDKCDEPLSI |
Function
Ubiquitin-like protein which plays a key role in the innate immune response to viral infection either via its conjugation to a target protein (ISGylation) or via its action as a free or unconjugated protein (PubMed:27564865, PubMed:39465252). ISGylation involves a cascade of enzymatic reactions involving E1, E2, and E3 enzymes which catalyze the conjugation of ISG15 to a lysine residue in the target protein (PubMed:33727702). Its target proteins include IFIT1, MX1/MxA, PPM1B, UBE2L6, UBA7, CHMP5, CHMP2A, CHMP4B and CHMP6. Isgylation of the viral sensor IFIH1/MDA5 promotes IFIH1/MDA5 oligomerization and triggers activation of innate immunity against a range of viruses, including coronaviruses, flaviviruses and picornaviruses (PubMed:33727702). Can also isgylate: EIF2AK2/PKR which results in its activation, RIGI which inhibits its function in antiviral signaling response, EIF4E2 which enhances its cap structure-binding activity and translation-inhibition activity, UBE2N and UBE2E1 which negatively regulates their activity, IRF3 which inhibits its ubiquitination and degradation and FLNB which prevents its ability to interact with the upstream activators of the JNK cascade thereby inhibiting IFNA-induced JNK signaling. Exhibits antiviral activity towards both DNA and RNA viruses, including influenza A, HIV-1 and Ebola virus. Restricts HIV-1 and ebola virus via disruption of viral budding. Inhibits the ubiquitination of HIV-1 Gag and host TSG101 and disrupts their interaction, thereby preventing assembly and release of virions from infected cells. Inhibits Ebola virus budding mediated by the VP40 protein by disrupting ubiquitin ligase activity of NEDD4 and its ability to ubiquitinate VP40. ISGylates influenza A virus NS1 protein which causes a loss of function of the protein and the inhibition of virus replication. The secreted form of ISG15 can: induce natural killer cell proliferation, act as a chemotactic factor for neutrophils and act as a IFN-gamma-inducing cytokine playing an essential role in antimycobacterial immunity. The secreted form acts through the integrin ITGAL/ITGB2 receptor to initiate activation of SRC family tyrosine kinases including LYN, HCK and FGR which leads to secretion of IFNG and IL10; the interaction is mediated by ITGAL (PubMed:29100055)
Protein Sequence
10
MGWDLTVKML
20
AGNEFQVSLS
30
SSMSVSELKA
40
QITQKIGVHA
50
FQQRLAVHPS
60
GVALQDRVPL
70
ASQGLGPGST
80
VLLVVDKCDE
90
PLSILVRNNK
100
GRSSTYEVRL
110
TQTVAHLKQQ
120
VSGLEGVQDD
130
LFWLTFEGKP
140
LEDQLPLGEY
150
GLKPLSTVFM
160
NLRLRGGGTE
PGGRS
Gene Ontology
| Classification |
GO ID |
Description |
| Cellular Component |
GO:0005737 |
cytoplasm |
| Cellular Component |
GO:0005829 |
cytosol |
| Cellular Component |
GO:0022626 |
cytosolic ribosome |
| Cellular Component |
GO:0005576 |
extracellular region |
| Cellular Component |
GO:0005654 |
nucleoplasm |
| Cellular Component |
GO:0005634 |
nucleus |
| Molecular Function |
GO:0005178 |
integrin binding |
| Molecular Function |
GO:0031386 |
protein tag activity |
| Molecular Function |
GO:0003735 |
structural constituent of ribosome |
| Biological Process |
GO:0042742 |
defense response to bacterium |
| Biological Process |
GO:0051607 |
defense response to virus |
| Biological Process |
GO:0045087 |
innate immune response |
| Biological Process |
GO:0007229 |
integrin-mediated signaling pathway |
| Biological Process |
GO:0032020 |
ISG15-protein conjugation |
| Biological Process |
GO:0019941 |
modification-dependent protein catabolic process |
| Biological Process |
GO:0031397 |
negative regulation of protein ubiquitination |
| Biological Process |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway |
| Biological Process |
GO:0045071 |
negative regulation of viral genome replication |
| Biological Process |
GO:0030501 |
positive regulation of bone mineralization |
| Biological Process |
GO:0045648 |
positive regulation of erythrocyte differentiation |
| Biological Process |
GO:0032728 |
positive regulation of interferon-beta production |
| Biological Process |
GO:0032733 |
positive regulation of interleukin-10 production |
| Biological Process |
GO:0032461 |
positive regulation of protein oligomerization |
| Biological Process |
GO:0032729 |
positive regulation of type II interferon production |
| Biological Process |
GO:0070585 |
protein localization to mitochondrion |
| Biological Process |
GO:0032649 |
regulation of type II interferon production |
| Biological Process |
GO:0034340 |
response to type I interferon |
| Biological Process |
GO:0009615 |
response to virus |
Reference
PMID: N/A